Elevated DCD levels have also been found in the serum of breast cancer patients collected at the time of diagnosis,44 although DCD expression in these tumor cells is associated with advanced clinical stage and poor disease prognosis.45 By contrast, in our group of melanoma patients, lower level of DCD was a significant factor that predicted a metastatic outcome in AJCC stage II patients. This evidence concerns the gene DCD and breast carcinoma.